[1]解宝泉,姚仲欣.非小细胞肺癌并发肺栓塞患者微小核糖核酸-1233、血清碱性成纤维细胞生长因子、血细胞参数变化及与患者预后关系[J].陕西医学杂志,2023,52(10):1349-1353.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.014]
　XIE Baoquan,YAO Zhongxin.Changes of miR-1233,bFGF and blood cell parameters in NSCLC patients with pulmonary embolism and their relationship with prognosis[J].,2023,52(10):1349-1353.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.014]
点击复制

非小细胞肺癌并发肺栓塞患者微小核糖核酸-1233、血清碱性成纤维细胞生长因子、血细胞参数变化及与患者预后关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1349-1353
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Changes of miR-1233,bFGF and blood cell parameters in NSCLC patients with pulmonary embolism and their relationship with prognosis
作者:
解宝泉1; 姚仲欣2
(1.华北理工大学附属医院呼吸内科,河北 唐山 063000; 2.秦皇岛市中医医院放射科,河北 秦皇岛066000)
Author(s):
XIE Baoquan; YAO Zhongxin
(Department of Respiratory Medicine,Affiliated Hospital of North China University of Science and Technology,Tangshan 063000,China)
关键词:
急性肺栓塞;  非小细胞肺癌;  碱性成纤维细胞生长因子;  微小核糖核酸-1233;  血细胞参数;  危险分层;  预后
Keywords:
Acute pulmonary embolism;  Non-small cell lung cancer;  Basic fibroblast growth factor;  Microribonucleic acid-1233;  Blood cell parameters;  Hazard stratification;  Prognosis
分类号:
R 563.5
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.014
文献标志码:
A
摘要:
目的:探讨并发急性肺栓塞(APE)的非小细胞肺癌(NSCLC)患者血清碱性成纤维细胞生长因子(bFGF)、微小核糖核酸-1233(miR-1233)、血细胞参数的变化与危险分层及短期预后的关系。方法:采取病例对照研究方法,选取110例肺癌合并肺栓塞患者作为栓塞组、另外选取同期收治的肺癌但未合并肺栓塞的患者110例作为对照组,对比两组患者的血清bFGF、miR-1233、红细胞分布宽度(RDW)、血小板分布宽度(PDW)、血小板平均体积(MPV)、血小板淋巴细胞比率(PLR)、中性粒细胞淋巴细胞比率(NLR)水平,并按照不同危险分层将栓塞组进行分层对比,采用Logistic回归模型分析各项指标与急性肺栓塞的NSCLC患者的相关性。结果:栓塞组患者的bFGF、miR-1233、RDW、MPV、PLR、NLR水平均显著高于对照组,差异具有统计学意义(均P<0.05); 高风险组患者的bFGF、miR-1233、RDW、MPV、PLR、NLR水平均显著高于中低风险组患者,差异具有统计学意义(均P<0.05); 死亡组患者的bFGF、miR-1233、RDW、MPV、PLR、NLR水平均显著高于生存组患者,差异具有统计学意义(均P<0.05)。Logistic回归模型结果显示:ALB降低、NT-proBNP升高、合并房颤、合并肺部感染、bFGF升高、miR-1233升高、PLR升高、NLR升高是NSCLC合并肺栓塞患者不良预后结局的独立危险因素(均P<0.05)。结论:bFGF、miR-1233及血细胞参数与NSCLC发生肺栓塞有关,并且与患者治疗的不良预后结局关系密切。
Abstract:
Objective:To investigate the relationship between the changes of serum basic fibroblast growth factor(bFGF),microRNA-1233(miR-1233),blood cell parameters and risk stratification,short-term prognosis in non-small cell lung cancer(NSCLC)patients with acute pulmonary embolism(APE).Methods:A case-control study was conducted.110 patients with lung cancer complicated with APE were selected as the embolism group,and 110 patients with lung cancer but without APE were selected as the control group.The levels of serum bFGF,miR-1233,red blood cell distribution width(RDW),platelet distribution width(PDW),mean platelet volume(MPV),platelet lymphocyte ratio(PLR),and neutrophil lymphocyte ratio(NLR)were compared between the two groups,and the embolism group was stratified and compared according to different risk stratification.Logistic regression model was used to analyze the correlation between each index and NSCLC patients with APE.Results:The levels of bFGF,miR-1233,RDW,MPV,PLR and NLR in the embolism group were significantly higher than those in the control group(all P<0.05).The levels of bFGF,miR-1233,RDW,MPV,PLR and NLR in the high-risk group were significantly higher than those in the low-and medium-risk group(all P<0.05).The levels of bFGF,miR-1233,RDW,MPV,PLR and NLR in the death group were significantly higher than those in the survival group(all P<0.05).Logistic regression model results showed that decreased ALB,increased NT-proBNP,complicated with atrial fibrillation,complicated with pulmonary infection,increased bFGF,increased miR-1233,increased PLR,and increased NLR were independent risk factors for poor prognosis of NSCLC patients with APW(all P<0.05).Conclusion:BFGF,miR-1233,and blood cell parameters are associated with the occurrence of pulmonary embolism in NSCLC,and are closely related to the adverse prognosis of patient treatment.

参考文献/References:

[1] Thai AA,Solomon BJ,Sequist LV,et al.Lung cancer[J].Lancet,2021,398(10299):535-554.
[2] 浦柳美,黄国兰,潘天宇,等.甲磺酸奥希替尼治疗晚期非小细胞肺癌的效果及预后相关因素分析[J].中南医学科学杂志,2023,51(3):376-379.
[3] Bade C,Dela CC.Lung cancer 2020:Epidemiology,etiology,and prevention[J].Clin Chest Med,2020,41(1):1-24.
[4] 魏玉磊,刘腾飞,韩媛媛,等.新辅助化疗对ⅢA-N2期非小细胞肺癌淋巴结转移率及预后的影响[J].宁夏医科大学学报,2022,44(8):784-787,792.
[5] Thakur SK,Singh DP,Choudhary J.Lung cancer identification:A review on detection and classification[J].Cancer Metastasis Rev,2020,39(3):989-998.
[6] Singh V,Gor D,Padappayil RP,et al.A trilogy of submassive pulmonary embolism,non-small cell lung cancer with brain metastasis,kartagener's syndrome and its management with aspiration thrombectomy[J].Eur J Case Rep Intern Med,2022,9(3):3149.
[7] Xiong W,Du H,Ding W,et al.The association between pulmonary embolism and the cancer-related genomic alterations in patients with NSCLC[J].Respir Res,2020,21(1):185.
[8] 段敏丹,陈 雪,王 悦,等.微小RNA多态性和非小细胞肺癌遗传易感性关系研究[J].陕西医学杂志,2017,46(7):833-835,839.
[9] 任东峰,孙国芳.六君祛痰解毒汤联合化疗治疗非小细胞肺癌疗效及对患者血管内皮生长因子的影响[J].陕西中医,2020,41(1):63-65.
[10] 中华医学会,中华医学会肿瘤学分会,中华医学会杂志社.中华医学会肺癌临床诊疗指南(2018版)[J].中华肿瘤杂志,2018,40(12):935-964.
[11] 中华医学会心血管病学分会肺血管病学组.急性肺栓塞诊断与治疗中国专家共识(2015)[J].中华心血管病杂志,2016,44(3):197-211.
[12] Duma N,Santana-Davila R,Molina JR.Non-small cell lung cancer:Epidemiology,screening,diagnosis,and treatment[J].Mayo Clin Proc,2019,94(8):1623-1640.
[13] Li Y,Shang Y,Wang W,et al.Lung cancer and pulmonary embolism:What is the relationship?A review[J].J Cancer,2018,9(17):3046-3057.
[14] Kaminuma Y,Tanahashi M,Suzuki E,et al.Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy[J].Gen Thorac Cardiovasc Surg,2020,68(10):1156-1162.
[15] 乔景艳,王 芳,唐华平.肺癌合并肺栓塞41例患者临床特点分析[J].中国临床医生杂志,2023,51(1):47-49.
[16] 魏云佳,向可敏,李冬铭,等.老年非小细胞肺癌患者术后发生肺栓塞的影响因素[J].中国老年学杂志,2023,43(5):1061-1064.
[17] 张 倩,王倩薇.BNP、Hcy、bFGF在非小细胞肺癌合并肺栓塞患者血清中的表达及意义[J].广东医学,2021,42(4):440-443.
[18] 王 熠,童国强,计玉兵,等.非小细胞肺癌组织中NF-κB、AP-1、TLR2的表达及意义[J].癌症进展,2018,16(15):1872-1874,1881.
[19] 张 奇,沈观樵,赵晓飞,等.急性肺栓塞患者血清miR-1233水平检测及临床意义[J].中国卫生检验杂志,2019,29(3):307-309.
[20] 王少飞,郑洪飞,李金玲,等.不同危险分层急性肺栓塞患者D-二聚体与纤维蛋白原比值、中性粒细胞与淋巴细胞比值、白蛋白的变化及其与预后的关系研究[J].现代生物医学进展,2022,22(24):4758-4762.

相似文献/References:

[1]才 昊,韩 亮,李晓飞.LncRNA XIST通过调控miR-186-5p促进非小细胞肺癌的增殖和侵袭实验研究*[J].陕西医学杂志,2020,49(7):781.[doi:DOI:10.3969/j.issn.10007377.2020.07.004]
　CAI Hao,HAN Liang,LI Xiaofei..LncRNA XIST promotes proliferation and invasion of non-small cell lung cancer by regulating miR-186-5p[J].,2020,49(10):781.[doi:DOI:10.3969/j.issn.10007377.2020.07.004]
[2]王冠杰,王 鹏△.培美曲塞联合顺铂治疗非小细胞肺癌疗效及对患者细胞角质抗原21-1、磷酸化细胞外信号调节激酶水平的影响研究*[J].陕西医学杂志,2020,49(7):804.[doi:DOI:10.3969/j.issn.10007377.2020.07.009]
　WANG Guanjie,WANG Peng..Therapeutic effect of pemetrexed combined with cisplatin in treatment of non-small cell lung cancer and its influence on CYFRA21-1 and p-ERK levels[J].,2020,49(10):804.[doi:DOI:10.3969/j.issn.10007377.2020.07.009]
[3]王翠翠,耿利民△.血清癌胚抗原对表皮生长因子受体基因突变非小细胞肺癌分子靶向治疗疗效的预测价值[J].陕西医学杂志,2020,49(7):834.[doi:DOI:10.3969/j.issn.10007377.2020.07.018]
　WANG Cuicui,GENG Limin..Predictive value of serum CEA in molecular targeted therapy of non-small cell lung cancer patients with EGFR gene mutation[J].,2020,49(10):834.[doi:DOI:10.3969/j.issn.10007377.2020.07.018]
[4]信 波,张开亮△,宋晓鹏,等.雌激素受体β拮抗剂对非小细胞肺癌A549细胞增殖、迁移及侵袭能力的影响*[J].陕西医学杂志,2020,49(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.006]
　XIN Bo,ZHANG Kailiang,SONG Xiaopeng,et al.Effect of estrogen receptor β antagonist PHTPP on proliferation,migration and invasion of non-small cell lung cancer A549 cells[J].,2020,49(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.006]
[5]邸金娜,刘敬禹,张 莉.基于网络药理及分子对接技术对人参治疗非小细胞肺癌作用机制研究[J].陕西医学杂志,2021,50(6):669.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.007]
　DI Jinna,LIU Jingyu,ZHANG Li.Mechanism of ginseng in NSCLC treatment based on network pharmacology and molecular docking technology[J].,2021,50(10):669.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.007]
[6]惠 盼,谯钰琪,董济民,等.葡萄糖调节蛋白78表达与非小细胞肺癌临床病理特征相关性Meta分析[J].陕西医学杂志,2023,52(4):481.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.027]
[7]赵贺红,李 群.不同病情严重程度急性肺栓塞患者血清和肽素、白细胞介素-38、单核细胞计数/高密度脂蛋白胆固醇、D-二聚体/纤维蛋白原变化及预后影响因素分析[J].陕西医学杂志,2023,52(9):1186.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.016]
　ZHAO Hehong,LI Qun.Changes of serum copeptin,interleukin-38,monocyte to high-density lipoprotein ratio,D-dimer to fibrinogen ratio and prognostic factors in patients with acute pulmonary embolism of different severity[J].,2023,52(10):1186.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.016]
[8]王莉云,王会丽,盛国芳,等.奥西替尼二线治疗EGFR T790M突变非小细胞肺癌脑转移临床研究[J].陕西医学杂志,2024,(7):962.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.021]

备注/Memo

备注/Memo:
基金项目:河北省卫生健康委员会医学科学研究计划项目(20180781)
更新日期/Last Update: 2023-10-07